KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients

BACKGROUND: KRAS mutation is a negative predictive factor for treatment with anti-epidermal growth factor receptor antibody in metastatic colorectal cancer (CRC). KRAS mutation analysis is usually performed on primary tumour tissue because metastatic tissue is often not available. However, controver...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Knijn, N, Mekenkamp, L J M, Klomp, M, Vink-Börger, M E, Tol, J, Teerenstra, S, Meijer, J W R, Tebar, M, Riemersma, S, van Krieken, J H J M, Punt, C J A, Nagtegaal, I D
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2011
Предметы:
Molecular Diagnostics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065268/
https://ncbi.nlm.nih.gov/pubmed/21364579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.26
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы